February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Adolescents and young adults
- Advocacy
- Anal cancer
- Antioxidants
- AYA
- Bladder cancer
- Blood cancers
- Brain cancer
- Breast cancer
- Cancer care delivery
- Caregiving
- Chemotherapy
- Chronic lymphocytic leukemia
- Colorectal cancer
- ComboMATCH
- Communication
- COVID-19
- DCIS
- De-escalation
- Esophagus cancer
- Financial hardship
- Gallbladder cancer
- Gastroesophageal cancer
- Geriatric oncology
- GI cancer
- Green tea
- HAI chemotherapy
- Head and neck cancer
- Head and neck squamous cell carcinoma
- Health equity
- Hepatic arterial infusion chemotherapy.
- HER2+ breast cancer
- Hormone therapy
- Imaging
- Immune system therapy
- Immunotherapy
- Implementation science
- In memory
- Kidney cancer
- Language
- Late Effects
- Leiomyosarcoma
- Leukemia
- LGBTQ+
- Liver cancer
- Lung cancer
- Lymphoma
- Mammography
- Mantle cell lymphoma
- Melanoma
- Men's health
- Mesothelioma
- Minimal residual disease
- MRI
- Multiple myeloma
- Myelodysplastic syndrome
- Myeloma
- National Clinical Trials Network
- NCI-MATCH
- Neuropathy
- Non-Hodgkin lymphoma
- Non-small cell lung cancer
- Nose and sinus cancer
- Older adults
- Pancreatic cancer
- Pancreatic cysts
- Patient advocacy
- Patient care
- Patient education
- Patient navigation
- Patient-reported outcomes
- Penile cancer
- Peripheral T-cell lymphoma
- Personalized medicine
- Personalized screening
- Personalized treatment
- Precision medicine
- Prevention
- Prostate cancer
- Radiation therapy
- Rare cancer
- Rare cancers
- Real-world data
- Real-world evidence
- Registry studies
- Renal cell carcinoma
- Research results
- Sarcoma
- Screening
- Sexual and gender minorities
- Side effects
- Skin cancer
- Smoldering multiple myeloma
- Social genomics
- Soft tissue sarcoma
- Solid tumors
- Squamous cell carcinoma
- Surveillance
- Survivorship
- Symptom management
- Symptom science
- Targeted therapy
- Throat cancer
- Thyroid cancer
- Trial results
- Triple-negative breast cancer
- Tumor test
- Upper tract urothelial cancer
- Urothelial cancer